Astellas Pharma is a pharmaceutical company conducting business in more than 70 countries around the world. We are promoting the Focus Area Approach that is designed to identify opportunities for the continuous creation of new drugs to address diseases with high unmet medical needs by focusing on Biology and Modality. Furthermore, we are also looking beyond our foundational Rx focus to create Rx+® healthcare solutions that combine our expertise and knowledge with cutting-edge technology in different fields of external partners. Through these efforts, Astellas stands on the forefront of healthcare change to turn innovative science into VALUE for patients. For press releases, comments are closed. If you have any questions about a press release, please contact us directly at the media relations address listed on the final page of the press release at our corporate website. All content on this page is intended for a global audience. Please note local regulations may vary depending on location.